Public Company News

First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial

Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...

2023-08-25 20:58 3416

BEST Vietnam Partners with Techcombank to Boost Cashless Payments Through Dynamic QR Code

HANGZHOU, China, Aug. 25, 2023 /PRNewswire/ -- BEST Vietnam under BEST Inc., a leading integrated smart supply chain solutions and logistics services provider inChina and Southeast Asia, today announced a cooperation with Techcombank to enhance cashless payments through QR code scanning. Custo...

2023-08-25 20:16 5477

WiMi Developed Execution Platform for AutoAIM Analytics to Facilitate Machine Learning in Marketing

BEIJING, Aug. 25, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed the AutoAIM (Automatic Artificial Intelligence Marketing) analytical execution platfo...

2023-08-25 20:00 2729

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA

HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that the National Center for Drug Evaluatio...

2023-08-25 20:00 2849

51Talk Online Education Group Announces Second Quarter 2023 Results

SINGAPORE, Aug. 25, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its interim unaudited results for the second quarter endedJune 30, 2023. Second Quarter ...

2023-08-25 19:30 4808

Magnum Opus Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Magnum Opus Acquisition Limited (NYSE: OPA) ("Magnum Opus" or the "Company") announces that onAugust 22, 2023, as a result of the Company's failure to timely file with the Securities and Exchange Commission ("SEC") its Quarterly Report on Form 10-Q for the...

2023-08-25 18:50 4303

Tigermed Reports 2023 Interim Results

HANGZHOU, China, Aug. 25, 2023 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

2023-08-25 18:39 5030

TCL Electronics (01070.HK) Achieves Solid Growth in 2023 H1

Seizes market opportunities & scales up new businesses to empower second growth curve Results Highlights * Product mix optimisation proved effective, with the mid-to-high-end and large-screen strategy driving a 12.4% year-on-year increase in gross profit to HK$6,500 million and a 1.4 percentag...

2023-08-25 18:17 4823

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

YONGIN, South Korea, Aug. 25, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed a MOU at its headquarters in Yongin,South Korea with Eubiologics for a co-production of Euvichol, an oral cholera vaccine. Under the MOU, bo...

2023-08-25 15:14 2266

noco-noco Pte. Ltd. and Prime Number Acquisition I Corp. Announce Plan for Closing of Business Combination on August 25, 2023

* noco-noco Pte. Ltd. and Prime Number Acquisition I Corp. plan to consummate the business combination onAugust 25, 2023 * noco-noco Inc.'s shares and warrants are targeted to start trading on Nasdaq Capital Market onAugust 28, 2023 SINGAPORE and NEW YORK, Aug. 24, 2023 /PRNewswire/ -- noco-n...

2023-08-25 11:00 4026

Laekna, Inc. (2105.HK) Announces Interim Results 2023

* For the Phase II pivotal trial of Afuresertib (LAE002) + Paclitaxel for platinum-resistant recurrent ovarian cancer (PROFECTOR-II), the patients were fully enrolled and the topline data is expected in the late fourth quarter of 2023 * For the Phase Ib/III trial of Afuresertib + Fulvestrant ...

2023-08-25 08:00 3982

Ping An Health announces 2023 interim results

Managed care business delivers robust performance  Market leadership in corporate health management drives loss narrowing by 47.2% HONG KONG and SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health", Stock Code: 1833.H...

2023-08-24 21:00 5041

TD Holdings, Inc. Enters into a US$165 Million Procurement Agency Agreement

To march into the renewable energy sector, and create new curve for business performance SHENZHEN, China, Aug. 24, 2023 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider inChina today announced that the Company's wholly-owned subsidiary Shenz...

2023-08-24 20:30 4603

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer ...

2023-08-24 20:00 2360

WiMi Developed an Efficient Density-Peak Clustering Algorithm for Improving Policy Evaluation Performance

BEIJING, Aug. 24, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed DPCEngine, an efficient density-peak clustering algorithm for improving the performan...

2023-08-24 20:00 2129

Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA

HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that the New Drug Application (NDA) for its...

2023-08-24 20:00 2363

Farmmi Announces Update with Latest UK Order

LISHUI, China, Aug. 24, 2023 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, announced today its latest high-volume order for shipment to the UK. The latest order, approximately half of which is for new customers, is for the Compa...

2023-08-24 20:00 3911

ICZOOM to Present at H.C. Wainwright's 25th Annual Global Investment Conference

HONG KONG, Aug. 24, 2023 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), a B2B electronic component products e-commerce platform, announced today that the Company's CEO, Mr. Lei Xia, will present at H.C. Wainwright's 25th Annual Global Investment Conference at the Lot...

2023-08-24 19:47 3857

Meituan Announces Financial Results for the Three and Six Months Ended June 30, 2023

HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Meituan (HKG: 3690) (the "Company"), a leading technology-driven retail company inChina, today announced the unaudited consolidated results of the Company for the three and six months endedJune 30, 2023. Company Financial Highlights During this quarter, ...

2023-08-24 19:35 5089

Yunji Announces Second Quarter 2023 Unaudited Financial Results

HANGZHOU, China, Aug. 24, 2023 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced its unaudited financial results for the second quarter ended June 30, 2023[1]. Second Quarter 2023 Highlights * Total revenu...

2023-08-24 18:00 3807
1 ... 378379380381382383384 ... 771